Developing high performance lipoprotein density profiling for use in clinical studies relating to cardiovascular...

Area of Science:

• Biochemistry
• Medical Diagnostics
• Analytical Chemistry

Background:

• Early detection of cardiovascular disease (CVD) is vital for prevention as it is reversible in initial stages.
• Current screening methods analyze blood-borne lipoprotein subclasses, but the gold standard ultracentrifuge method lacks clinical precision.
• Distinguishing individuals with and without CVD using statistical methods is challenging with existing lipoprotein analysis precision.

Purpose of the Study:

• To identify and enhance key factors affecting the precision of lipoprotein density profile measurement using sedimentation equilibrium analysis.
• To improve the accuracy of CVD risk assessment through enhanced lipoprotein subclassification.
• To adapt the ultracentrifuge method for clinical applications by increasing measurement precision.

Main Methods:

• Sedimentation equilibrium analysis using ultracentrifugation.
• Labeling of lipoprotein subclasses with a fluorescent probe.
• Two-phase study focusing on ultracentrifugation variables and digital data conversion for statistical analysis.

Main Results:

• Achieved an overall improvement in measurement precision by a factor of 5.
• Successfully addressed factors influencing ultracentrifugation and fluorescent profile conversion.
• Enhanced precision is sufficient for application in CVD risk assessment classification studies.

Conclusions:

• The improved precision of lipoprotein density measurement by sedimentation equilibrium analysis is suitable for clinical CVD risk assessment.
• This enhanced method overcomes previous limitations in distinguishing individuals with and without CVD.
• The study provides a more accurate tool for early cardiovascular disease detection and prevention strategies.